Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS · Delayed Price · Currency is USD
0.0010
+0.0007 (232.23%)
Sep 5, 2025, 11:19 AM EDT
Acura Pharmaceuticals Market Cap
Acura Pharmaceuticals has a market cap or net worth of $66.50 thousand as of September 5, 2025. Its market cap has decreased by -99.71% in one year.
Market Cap
66.50K
Enterprise Value
n/a
Revenue
1.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 17, 1986, Acura Pharmaceuticals's market cap has decreased from 7.10M to 66.50K, a decrease of -99.06%. That is a compound annual growth rate of -11.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 66.50K | 401.12% |
| Dec 31, 2024 | 13.27K | 100.57% |
| Dec 29, 2023 | 6.62K | -99.80% |
| Dec 30, 2022 | 3.28M | -89.93% |
| Dec 31, 2021 | 32.54M | 615.81% |
| Dec 31, 2020 | 4.55M | -7.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 760.21M |
| Tian'an Technology Group | 673.67M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 387.41M |